Fraud

Court reverses Risperdal decision

The Arkansas Supreme Court's decision puts $1.2 billion back into J&J's coffers.

Business briefs: GSK, DOJ, Sanofi, Flashpoint Medica

GSK boots Shanghai R&D head over data fabrication; DOJ backs off of Plan B; Sanofi scores approval for new flu vaccine; laurels for Flashpoint Medica's Charlene Prounis

Email Newsletters